Jeffrey T. Safrit
About
Jeffrey T. Safrit is a scholar working on Virology, Immunology and Infectious Diseases.
According to data from OpenAlex, Jeffrey T. Safrit has authored 54 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Virology, 33 papers in Immunology and 25 papers in Infectious Diseases. Recurrent topics in Jeffrey T. Safrit's work include HIV Research and Treatment (37 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS Research and Interventions (17 papers). Jeffrey T. Safrit is often cited by papers focused on HIV Research and Treatment (37 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS Research and Interventions (17 papers). Jeffrey T. Safrit collaborates with scholars based in United States, Netherlands and Zambia. Jeffrey T. Safrit's co-authors include David D. Ho, Richard A. Koup, Charla Andrews, William Borkowsky, Gavin X. McLeod, Charles Farthing, Yaming Cao, Linqi Zhang, Yunzhen Cao and Xia Jin and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
In The Last Decade
Jeffrey T. Safrit
52 papers receiving 5.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey T. Safrit United States | 28 | 5.0k | 3.6k | 2.1k | 1.5k | 842 | 54 | 6.1k | ||
| Guido Ferrari United States | 45 | 3.8k 0.8× | 3.3k 0.9× | 1.7k 0.8× | 1.4k 0.9× | 1.3k 1.5× | 191 | 5.8k | ||
| Stephen A. Migueles United States | 35 | 5.3k 1.1× | 4.7k 1.3× | 2.1k 1.0× | 1.5k 1.0× | 871 1.0× | 67 | 7.1k | ||
| Florencia Pereyra United States | 44 | 4.2k 0.8× | 3.7k 1.0× | 1.8k 0.9× | 1.1k 0.7× | 905 1.1× | 74 | 6.1k | ||
| Georgia D. Tomaras United States | 44 | 4.5k 0.9× | 3.7k 1.0× | 1.8k 0.8× | 1.4k 0.9× | 1.5k 1.8× | 190 | 6.4k | ||
| Nancy L. Haigwood United States | 43 | 4.6k 0.9× | 3.1k 0.9× | 2.0k 0.9× | 1.6k 1.1× | 1.5k 1.8× | 133 | 6.5k | ||
| Jesus F. Salazar-Gonzalez United States | 20 | 3.9k 0.8× | 2.1k 0.6× | 2.0k 0.9× | 1.1k 0.8× | 1.0k 1.2× | 36 | 5.1k | ||
| Donald L. Sodora United States | 40 | 3.8k 0.8× | 2.9k 0.8× | 1.6k 0.7× | 1.9k 1.3× | 478 0.6× | 90 | 5.4k | ||
| Cynthia A. Derdeyn United States | 35 | 5.0k 1.0× | 2.2k 0.6× | 3.0k 1.4× | 1.2k 0.9× | 982 1.2× | 85 | 5.7k | ||
| Michael Piatak United States | 42 | 6.0k 1.2× | 3.8k 1.1× | 3.0k 1.4× | 2.3k 1.6× | 1.0k 1.2× | 117 | 7.9k | ||
| James F. Demarest United States | 25 | 3.9k 0.8× | 2.7k 0.8× | 2.0k 0.9× | 1.2k 0.9× | 418 0.5× | 46 | 5.1k |
Countries citing papers authored by Jeffrey T. Safrit
Since
Specialization
Citations
This map shows the geographic impact of Jeffrey T. Safrit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey T. Safrit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey T. Safrit more than expected).
Fields of papers citing papers by Jeffrey T. Safrit
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jeffrey T. Safrit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey T. Safrit. The network helps show where Jeffrey T. Safrit may publish in the future.
Co-authorship network of co-authors of Jeffrey T. Safrit
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey T. Safrit. A scholar is included among the top collaborators of Jeffrey T. Safrit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey T. Safrit. Jeffrey T. Safrit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rice, Adrian, Mohit S. Verma, Emily A. Voigt, et al.. (2022). Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies. Frontiers in Immunology. 13. 910136–910136.
2.
Chu, Yaya, Gaurav Nayyar, Jeremy Rosenblum, et al.. (2021). Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. Journal for ImmunoTherapy of Cancer. 9(7). e002267–e002267.
3.
Rice, Adrian, Mohit S. Verma, Peter A. Sieling, et al.. (2021). Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice. Scientific Reports. 11(1).
4.
Chu, Yaya, Gaurav Nayyar, Nang Kham Su, et al.. (2020). Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Journal for ImmunoTherapy of Cancer. 8(2). e001238–e001238.
5.
Guldevall, Karolin, Paul K.J.D. de Jonge, Janneke S. Hoogstad‐van Evert, et al.. (2020). IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. Cancer Immunology Immunotherapy. 70(5). 1305–1321.
6.
Tiam, Appolinaire, Michelle M. Gill, Heather J. Hoffman, et al.. (2017). Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks?. PLoS ONE. 12(10). e0184769–e0184769.
7.
Safrit, Jeffrey T. & Wayne C. Koff. (2016). Novel approaches in preclinical HIV vaccine research. Current Opinion in HIV and AIDS. 11(6). 601–606.
8.
Mofenson, Lynne, Coleen K. Cunningham, Mary Glenn Fowler, et al.. (2014). HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission. PLoS Medicine. 11(4). e1001616–e1001616.
9.
Benjamin, H., Moses Sinkala, Ronald A. Cantrell, et al.. (2008). Single-Dose Tenofovir and Emtricitabine for Reduction of Viral Resistance to Non-nucleoside Reverse Transcriptase Inhibitory Drugs in Women Given Intrapartum Nevirapine for Perinatal HIV Prevention: An Open-Label Randomized Trial. Obstetrical & Gynecological Survey. 63(4). 206–207.
10.
Benjamin, H., Moses Sinkala, Ronald A. Cantrell, et al.. (2007). Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. The Lancet. 370(9600). 1698–1705.
11.
Buckner, Clarisa M., Lucia Vojtech, Indresh K. Srivastava, et al.. (2004). Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV. Virology. 320(1). 167–180.
12.
Montefiori, David C., Jeffrey T. Safrit, Shari L. Lydy, et al.. (2001). Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus Macaques. Journal of Virology. 75(13). 5879–5890.
13.
Ferris, Robert L., Christopher S. Hall, Nikolaos V. Sipsas, et al.. (1999). Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization. The Journal of Immunology. 162(3). 1324–1332.
14.
Cao, Yunzhen, et al.. (1995). Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. New England Journal of Medicine. 332(4). 201–208.
15.
Hammond, Scott A., R. Paul Johnson, Spyros A. Kalams, et al.. (1995). An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.. The Journal of Immunology. 154(11). 6140–6156.
16.
Safrit, Jeffrey T.. (1995). The immunology of primary HIV infection: which immune responses control HIV replication?. Current Opinion in Immunology. 7(4). 456–461.
17.
Koup, Richard A., R M Hesselton, Jeffrey T. Safrit, Mohan Somasundaran, & John L. Sullivan. (1994). Quantitative Assessment of Human Immunodeficiency Virus Type 1 Replication in Human Xenografts of Acutely Infected Hu-PBL-SCID Mice. AIDS Research and Human Retroviruses. 10(3). 279–284.
18.
Safrit, Jeffrey T., Charla Andrews, Tuofu Zhu, David D. Ho, & R Koup. (1994). Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.. The Journal of Experimental Medicine. 179(2). 463–472.
19.
Safrit, Jeffrey T., et al.. (1994). A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.. The Journal of Immunology. 153(8). 3822–3830.
20.
Safrit, Jeffrey T. & Benjamin Bonavida. (1992). Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins. Cancer Immunology Immunotherapy. 34(5). 321–328.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Guido Ferrari Breakdown of academic impact, for papers by Stephen A. Migueles Breakdown of academic impact, for papers by Florencia Pereyra Breakdown of academic impact, for papers by Georgia D. Tomaras Breakdown of academic impact, for papers by Nancy L. Haigwood Breakdown of academic impact, for papers by Jesus F. Salazar-Gonzalez Breakdown of academic impact, for papers by Donald L. Sodora Breakdown of academic impact, for papers by Cynthia A. Derdeyn Breakdown of academic impact, for papers by Michael Piatak Breakdown of academic impact, for papers by James F. Demarest